- The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (consensus). N Engl J Med 1987; 316: 1429–1435.
- The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685–691.
- Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boissel JP. Clinical effect of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 1998; 98: 1184–1191.
- The CIBIS II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (C1BIS 11): a randomized trial. Lancet 1999; 353: 9–13.
- Anon. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001–2007.
- Dhalla KS, Rupp H, Beamish RE, Dhalla NS. Mechanisms of alteration in cardiac membrane Ca' transport due to excess catecholamines. Cardiovasc Drugs Ther 1996; 10: 231–238.
- Hill MF, Singal PK. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol1996; 148: 291-300.
- Dhalla KS, Hill MF, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 1996;28: 506–514.
- Simpson P, McGrath A, Savion S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res 1982; 51: 787–801.
- Wu CF, Bishopric NH, Pratt RE. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem 1997;272: 14860–14866.
- Communal C, Singh K, Pimentel DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation 1998; 98: 1329–1334.
- Iwai-Kanai E, Hasegawa K, Araki M, Katika T, Morimoto T, Sasayama S. Alpha and beta-adrenergic pathways differentially regulate cell type specific apoptosis in rat cardiac myocytes. Circulation 1999; 100: 305–311.
- Pfeffer MA, Pfeffer JM, Fishbein MC et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979; 44: 503–512.
- Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976; 15: 212–216.
- De Haan JB, Newman JD, Kola I. Cu/Zn superoxide dismutase mRNA and enzyme activity, and susceptibility to lipid peroxidation, increases with aging in murine brains. Mol Brain Res 1992; 13: 179–187.
- Paglia DE, Valentine WN. Studies of the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158–169.
- Yue T, Cheng H, Lysko PG et al. Carvedilol, a new vasodilator and beta adrenoreceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 1992; 263: 92–98.
- Berlin I, Said S, Spreux-Varoquaux 0, Olivares R, Launay JM, Puech AJ. Monoamine oxidase A and B activities in heavy smokers. Biol Psychiatry 1995;38: 756–761.
- Mansuy P. Mougenot N, Ramirez-Gil JF et al. Effects of prolonged propranolol treatment on left ventricular remodelling and oxidative stress after myocardial infarction in rats. J Cardiovasc Pharmacol 2000; 35: 806–813.
- Shizukuda Y, Buttrick PM, Geenen DL, Borczuk AC, Kitsis RN, Sonnenblick EH. P-Adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol 1998;275: H961–H968.
- McMurray J, Chopra M, Abdullah I, Smith WE, Dargie HJ. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J1993; 14: 1493-1498.
- Diaz-Velez CR, Garcia-Castineiras S, Mendoza-Ramos E, Hernandez-Lopez E. Increased malondialdehyde in peripheral blood of patients with congestive heart failure. Am Heart J1995; 131: 146-152.
- Remiao F, Carmo H, Carvalho FD, Bastos MI. Inhibition of glutathione reductase by isoproterenol oxidation products. J Enzyme Inhib 2000; 15: 47–61.
- Wagner KD, Geil D, Schimke I et al. Decreased susceptibility of contractile function to hypoxia/reoxygenation in chronic infarcted rat hearts. J Mol Cell Cardiol 1998; 30: 2341–2353.
- Hill MF, Singal PK. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 1997; 96: 2414–2420.
- Schieffer B, Wirger A, Meybrunn M et al. Comparative effects of chronic angiotensin-converting enzyme inhibition on angiotensin II type 1 receptor blockade on cardiac remodelling after myocardial infarction in the rat. Circulation 1994; 89: 2273–2282.
- Cioca DP, Watanabe N, Isobe M. Apoptosis of peripheral blood lymphocytes is induced by catecholamines. Jpn Heart J 2000; 41: 385–398.
- Zaugg M, Xu W, Lucchinetti E, Shafiq SA, Jamali NZ, Siddiqui MA. Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 2000; 102: 344–350.
- Singh K, Communal C, Sawyer DB, Colucci WS. Adrenergic regulation of myocardial apoptosis. Cardiovasc Res 2000; 45: 713–719.
- Henaff M, Hatem SN, Mercadier JJ. Low catecholamine concentrations protect adult rat ventricular myocytes against apoptosis through cAMP-dependent extracellular signal-regulated kinase activation. Mol Pharmacol 2000; 58: 1546–1553.
- Qin F, Rounds NK, Mao W, Kawai K,Liang C-S. Antioxidant vitamins prevent cardiomyocyte apoptosis produced by norepinephrine infusion in ferrets. Cadiovasc Res 2031; 51:736-748.
- Bristow MR, Ginsburg R, Umans V et al. Beta 1 and beta 2 adrenergic receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective 01 receptor down regulation in heart failure. Circ Res 1986; 59: 297–309.
- Neumann J, Schmitz W, Scholz H, von Meyerinck L, Doring V, Kalmar P. Increase in myocardial Grproteins in heart failure. Lancet 1988;2: 936–937.
- Böhm M, La Rose K, Schwinger RHG, Erdmann E. Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol 1995;25: 146–153.
- Schwartz DD, Naff BP. Activation of protein kinase C by angiotensin II decreases Pradrenergic receptor responsiveness in the rat heart. J Cardiovasc Pharmacol 1997; 29: 257–264.
Free access
Catecholamine effects on cardiac remodelling, oxidative stress and fibrosis in experimental heart failure
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.